Medicina

Journal Browser

► Journal Browser

Pancreatitis—Advances in Diagnosis and Management of Acute, Chronic, Autoimmune and Postoperative Pancreatitis

Share This Special Issue

Special Issue Editor

Dr. Vishal G. Shelat

E-Mail Website
Guest Editor

1. Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore
2. Surgical Science Training Centre, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore
Interests: hepato-pancreato-biliary surgery; surgical infection; healthcare ethics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The pancreas (Pan = all, Kreas = flesh) is the meeting place of medicine and surgery. The retroperitoneal location poses challenges to clinical presentation and limits physical examination, the extra-luminal location reduces access via routine luminal endoscopy, and combined endocrine and exocrine functions bring to life complex medical and surgical considerations that are best dealt with by multidisciplinary care teams that include physicians with a special interest in the pancreas.

Pancreatitis, i.e., inflammation of the pancreas, can be acute, chronic, autoimmune or postoperative in nature. With advances in diagnostic imaging and enhanced understanding of the pathobiology of pancreatitis, diagnostic and management approaches have evolved over past decades. Acute pancreatitis can be generally biliary or alcoholic in aetiology; however, a wide spectrum of aetiology exists, including COVID-19. Chronic pancreatitis is generally evident in patients with alcoholism, but genetic or dietary factors may also play a role. Recently, autoimmune and postoperative pancreatitis have been increasingly reported using diagnostic criteria and guidelines for management.

In this Special Issue, I welcome submissions on a wide and broad range of issues relating to any form of pancreatitis, and any potential authors are welcome to submit presubmission inquiries to me. Clinical features, imaging considerations, biochemical indices, management approaches, endoscopic interventions, interventional radiology, surgical novelties, basic and translational research, artificial intelligence, and technological advances relating to pancreatitis are welcome. All submissions will be processed within the guidelines of the journal.

Dr. Vishal G. Shelat
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

acute pancreatitis
autoimmune pancreatitis
chronic pancreatitis
imaging
research
technology

Published Papers (2 papers)

Download All Papers

Research

Jump to: Other

13 pages, 1121 KiB

Open AccessArticle

Performance of European and American Societies of Gastrointestinal Endoscopy Guidelines for Prediction of Choledocholithiasis in Patients with Acute Biliary Pancreatitis

by Žan Peter Černe, Nejc Sever, Luka Strniša, Samo Plut, Jan Drnovšek, Jurij Hanžel, Darko Siuka, Borut Štabuc and David Drobne

Medicina 2023, 59(12), 2176; https://doi.org/10.3390/medicina59122176 - 15 Dec 2023

Viewed by 1125

Abstract

Background and Objectives: Up to one-third of patients with acute biliary pancreatitis also present with choledocholithiasis. Guidelines from the European Society of Gastrointestinal Endoscopy (ESGE) and the American Society for Gastrointestinal Endoscopy (ASGE) for investigating suspected choledocholithiasis suggest endoscopic retrograde cholangiopancreatography in patients with high-likelihood (ESGE)/high-probability (ASGE) predictors and endoscopic ultrasound in those with intermediate-likelihood (ESGE)/intermediate-probability (ASGE) predictors. Although both guidelines are similar, they are not identical. Furthermore, these algorithms were mainly developed from cohorts of patients without pancreatitis and are therefore poorly validated in a subset of patients with acute pancreatitis. We aimed to assess the performance of the ESGE and ASGE algorithms for the prediction of choledocholithiasis in patients with acute biliary pancreatitis. Materials and Methods: This was a retrospective analysis of 86 consecutive patients admitted to a tertiary referral centre in the year 2020 due to acute biliary pancreatitis. Results: Choledocholithiasis was confirmed in 29/86 (33.7%) of patients (13 with endoscopic retrograde cholangiopancreatography and 16 with endoscopic ultrasound). All 10/10 (100%) ESGE high-likelihood and 14/19 (73.7%) ASGE high-probability patients had choledocholithiasis. Only 19/71 (26.8%) patients with ESGE intermediate likelihood and 15/67 (22.4%) with ASGE intermediate probability had choledocholithiasis. Only 8/13 (61.5%) patients with the ASGE high-probability predictor of dilated common bile duct plus bilirubin > 68.4 µmol/mL had choledocholithiasis. Since this predictor is not considered high likelihood by ESGE, this resulted in a superior specificity of the European compared to the American guideline (100% vs. 91.2%). Following the American instead of the European guidelines would have resulted in five unnecessary endoscopic retrograde cholangiopancreatographies and five unnecessary endoscopic ultrasound examinations. Conclusions: This retrospective analysis suggests that the European guidelines may perform better than the American guidelines at predicting choledocholithiasis in the setting of acute pancreatitis. This was because dilated common bile duct plus bilirubin > 68.4 µmol/mL was not a reliable predictor for persistent bile duct stones. Full article

(This article belongs to the Special Issue Pancreatitis—Advances in Diagnosis and Management of Acute, Chronic, Autoimmune and Postoperative Pancreatitis)

► Show Figures

Figure 1

Other

Jump to: Research

6 pages, 1414 KiB

Open AccessCase Report

Emphysematous Pancreatitis as a Life-Threatening Condition: A Case Report and Review of the Literature

by Aleksandar Filipović, Dragan Mašulović, Dušan Bulatović, Miloš Zakošek, Aleksa Igić and Tamara Filipović

Medicina 2024, 60(3), 406; https://doi.org/10.3390/medicina60030406 - 27 Feb 2024

Viewed by 952

Abstract

Emphysematous pancreatitis represents the presence of gas within or around the pancreas on the ground of necrotizing pancreatitis due to superinfection with gas-forming bacteria. This entity is diagnosed on clinical grounds and on the basis of radiologic findings. Computed tomography is the preferred imaging modality used to detect this life-threating condition. The management of emphysematous pancreatitis consists of conservative measures, image-guided percutaneous catheter drainage or endoscopic therapy, and surgical intervention, which is delayed as long as possible and undertaken only in patients who continue to deteriorate despite conservative management. Due to its high mortality rate, early and prompt recognition and treatment of emphysematous pancreatitis are crucial and require individualized treatment with the involvement of a multidisciplinary team. Here, we present a case of emphysematous pancreatitis as an unusual occurrence and discuss disease features and treatment options in order to facilitate diagnostics and therapy. Full article

(This article belongs to the Special Issue Pancreatitis—Advances in Diagnosis and Management of Acute, Chronic, Autoimmune and Postoperative Pancreatitis)

► Show Figures